Daijiworld Media Network - New Delhi
New Delhi, Oct 7: Changes involving several interconnected brain networks may help explain cancer-related cognitive impairment among breast cancer survivors, according to a review of neuroimaging studies.
Cancer-related cognitive impairment can affect memory, attention, concentration and processing speed, with symptoms sometimes continuing for years after treatment. The mechanisms behind these difficulties and their relationship with measurable changes in the brain, however, remain incompletely understood.
Researchers reviewed six diffusion tensor imaging studies involving 282 participants, six voxel-based morphometry studies involving 177 participants and 10 functional MRI studies involving 328 participants. The imaging techniques provided different perspectives on structural and functional changes in the brain.
Using the Yeo seven-network atlas, the researchers examined whether brain regions associated with cognitive impairment overlapped with established functional networks. Statistical analyses were then used to assess associations between the reported changes and specific networks.
The analysis identified significant associations involving the dorsal attention, default mode, frontoparietal and ventral attention networks. The default mode and frontoparietal networks were highlighted as particularly relevant for further research into disease monitoring and potential therapeutic approaches.
However, the pattern of associations differed between imaging techniques, suggesting that the various methods captured different aspects of brain alterations.
The findings indicate that cancer-related cognitive impairment may involve multiple interconnected brain networks rather than being limited to a single region. This could help explain why survivors experience difficulties across several cognitive functions and during demanding everyday activities.
The researchers stressed that the findings do not establish that changes in any particular network directly cause an individual's symptoms. Instead, they provide a framework for further investigation into the neural processes that may contribute to cognitive difficulties following breast cancer treatment.
The review had several limitations, including the relatively small number of studies and differences in treatment regimens, patient characteristics, imaging methods and the timing of assessments. Brain scans conducted shortly after treatment may reflect different processes from those performed years later.
Most of the studies also did not systematically account for factors such as depression, anxiety, fatigue and menopausal status. In addition, the review primarily considered studies reporting positive neuroimaging findings, potentially limiting the overall picture.
The researchers noted that evidence linking early MRI changes with long-term cognitive outcomes remains limited. MRI is therefore not currently established as a routine screening tool for cancer-related cognitive impairment.
The findings could nevertheless help guide future research into potential biomarkers and targeted interventions. More consistent assessment methods and studies incorporating both positive and negative findings may help determine how these brain changes could eventually contribute to survivorship care.